Clinical Trial Landscape of Duchenne Muscular Dystrophy in Europe: A 10-Year Retrospective Analysis

Chronic Inflammation, Fibrotic Remodeling, and Regenerative Failure in Duchenne Muscular Dystrophy: Mechanisms and Therapeutic Opportunities
Jie Shi, Jiao Yang
Biomedicines28 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Structural engineering of dual-targeting antisense oligonucleotides enhances exon 44 skipping for treating Duchenne muscular dystrophy
G. Shoffner, F. Barthelemy, J. Pi +6
bioRxiv1 Oct 2026PreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
Human and zebrafish data corroborate gene x gene interactions in ameliorating Duchenne muscular dystrophy disease progression
V. J. Vieland, G. T. Lerma, S.-C. Seok +5
medRxiv1 Nov 2026PreprintAll rights reservedFull textHuman geneticsmedRxiv
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy: the NEBIDYS trial
Luca Monzo, Henri-Marc Becane, Yves Dulac +14
European Heart Journal - Cardiovascular Pharmacotherapy7 Oct 2026Peer-reviewedCC BY 4.0Full textCardiovascular medicineHAL
Duchenne muscular dystrophy-associated cardiomyopathy: advances in diagnosis and management
GU Jie, LIU Yu-Hang, HONG Si-Qi
中国当代儿科杂志23 Oct 2026Peer-reviewedCC BY-NC-NDFull textCardiovascular medicineDOAJ

Cite

BibTeX

@article{telbiyski2026clinical,
  title = {{Clinical Trial Landscape of Duchenne Muscular Dystrophy in Europe: A 10-Year Retrospective Analysis}},
  author = {Petar Telbiyski and Radiana Staynova},
  journal = {Medicina (Kaunas, Lithuania)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13706884},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Clinical Trial Landscape of Duchenne Muscular Dystrophy in Europe: A 10-Year Retrospective Analysis
AU  - Petar Telbiyski
AU  - Radiana Staynova
PY  - 2026
DA  - 2026/10/01
JO  - Medicina (Kaunas, Lithuania)
UR  - https://europepmc.org/article/PMC/PMC13706884
SN  - 1010-660X
SN  - 1648-9144
ER  -

Related

Cite